Synthesis and Cytotoxic Activity of Combretastatin A-4 and 2,3-Diphenyl-2H-indazole Hybrids (original) (raw)

Design and synthesis of pironetin analogue/combretastatin A-4 hybrids containing a 1,2,3-triazole ring and evaluation of their cytotoxic activity

Miguel Carda

European journal of medicinal chemistry, 2014

View PDFchevron_right

Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines

Michael Zavelevich, Gábor Maász

Bioorganic & Medicinal Chemistry, 2014

View PDFchevron_right

Synthesis and Antitumor Activity of 1,5-Disubstituted 1,2,4-Triazoles as Cis-Restricted Combretastatin Analogues

Giampietro Viola

Journal of Medicinal Chemistry, 2010

View PDFchevron_right

Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents

Vrinda sharma

Anti-Cancer Agents in Medicinal Chemistry, 2015

View PDFchevron_right

Synthesis and antineoplastic activity of combretastatin analogues: Heterocombretastatins

Arturo San Feliciano

European Journal of Medicinal Chemistry, 1998

View PDFchevron_right

Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids

Pradeep Kumar, Mariusz Jaremko

Pharmaceuticals, 2022

View PDFchevron_right

Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues

Mahmoud Ibrahim

European journal of medicinal chemistry, 2017

View PDFchevron_right

Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids

Nitish Kumar

European Journal of Medicinal Chemistry, 2014

View PDFchevron_right

Synthesis, Structure and In Vitro Cytotoxic Activity of Novel Cinchona—Chalcone Hybrids with 1,4-Disubstituted- and 1,5-Disubstituted 1,2,3-Triazole Linkers

laszlo kohidai

Molecules, 2019

View PDFchevron_right

DESIGN, SYNTHESIS AND IN VITRO ANTI-CANCER ACTIVITY OF NOVEL 1,2,4-TRIAZOLE DERIVATIVES

International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS), ESHWAR M. S.

International journal of Pharmacy and Pharmaceutical Sciences, 2014

View PDFchevron_right

DESIGN, SYNTHESIS AND IN VITRO ANTI-CANCER ACTIVITY OF NOVEL 1,2,4-TRIAZOLE DERIVATIVES Original Article

Madhusudan Purohit

View PDFchevron_right

Advances in Synthetic Approaches for the Preparation of Combretastatin-Based Anti-Cancer Agents

rohit singh

Synthesis, 2009

View PDFchevron_right

Synthesis and antitumor activity of benzils related to combretastatin A-4

Abdallah Hamze

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right

Design, Synthesis, in Silico and in Vitro Evaluation of New Combretastatin A-4 Analogs as Antimitotic Antitumor Agents

Ammar Kubba

Medicinal Chemistry, 2023

View PDFchevron_right

Design, Synthesis, and Investigation of Cytotoxic Activity of cis-Vinylamide-Linked Combretastatin Analogues as Potential Anticancer Agents

Islam Zaki

Symmetry

View PDFchevron_right

Synthesis and biological evaluation of combretastatin A-4 and three combretastatin-based hybrids

Miguel González

Natural product communications, 2012

View PDFchevron_right

Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents

Luisa Lopez-Cara

European Journal of Medicinal Chemistry, 2017

View PDFchevron_right

1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin

Sylvie Ducki

Bioorganic & Medicinal Chemistry, 2008

View PDFchevron_right

Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids

Laura Škarnulytė

ACS Medicinal Chemistry Letters, 2018

View PDFchevron_right

Synthesis of combretastatin A-4 O-alkyl derivatives and evaluation of their cytotoxic, antiangiogenic and antitelomerase activity

Santiago Diaz Oltra

Bioorganic & Medicinal Chemistry, 2013

View PDFchevron_right

Combretazet-3 a novel synthetic cis-stable combretastatin A-4- azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer

Daniela Zisterer

Oncology Reports, 2013

View PDFchevron_right

Design, Synthesis and Cytotoxic Evaluation of 4-Anilinoquinazoline– triazole–AZT Hybrids as Anticancer Agents

Vu Quoc Trung

Natural Product Communications

View PDFchevron_right

Design, Synthesis, and Biological Evaluations of 2,5Diaryl2,3-dihydro-1,3,4-oxadiazoline Analogs of Combretastatin-A4

balaji babu

Journal of Medicinal Chemistry, 2010

View PDFchevron_right

Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4

Roland BARRET

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right